Company Filing History:
5 out of 3,539 
3 out of 810 
2 out of 71 
Years Active: 2005-2011
Title: The Innovative Contributions of Catherine Y Spong
Introduction
Catherine Y Spong is a prominent inventor based in Arlington, VA (US), known for her significant contributions to the field of biomedical research. With a total of 6 patents, her work focuses on developing innovative solutions to prevent cell damage and address conditions associated with fetal alcohol syndrome.
Latest Patents
One of her latest patents, titled "Orally active peptides that prevent cell damage and death," presents an ADNF polypeptide that includes an active core site with at least one D-amino acid. This invention also encompasses a pharmaceutical composition that is orally active, aimed at reducing neuronal cell death and oxidative stress. Another notable patent, "Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides," outlines methods for mitigating conditions related to fetal alcohol syndrome in subjects exposed to alcohol in utero. This patent emphasizes the use of a mixture of ADNF I and ADNF III polypeptides to achieve these health benefits.
Career Highlights
Catherine has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Ramot at Tel Aviv University Ltd. Her career reflects a commitment to advancing medical science and improving health outcomes through innovative research.
Collaborations
Throughout her career, Catherine has collaborated with notable colleagues, including Douglas E Brenneman and Illana Gozes, further enhancing the impact of her research.
Conclusion
Catherine Y Spong's innovative work in developing orally active peptides and addressing fetal alcohol syndrome showcases her dedication to improving health through scientific advancements. Her contributions continue to influence the field of biomedical research and offer hope for better health solutions.